It Takes a Team: Treating Adverse Events


A multidisciplinary care team is needed when treating patients who are given a combination of chemotherapy and immunotherapy.

When treating patients with chemotherapy plus an immunotherapy agent, a multidisciplinary team should be on call to manage adverse events (AEs), explained Matthew A. Gubens, MD, MS, associate professor of thoracic medical oncology at the UCSF Helen Diller Family Comprehensive Cancer Center.

The combination is usually well-tolerated, with typical chemotherapy AEs occurring, such as nausea and vomiting. When it comes to immunotherapy, the same AEs that would be expected if the drug was given as a single agent could be expected, Gubens said.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.